课题基金 / 基金详情

SESAR3 ATM Master Planning and Monitoring

SESAR3 ATM Master Planning and Monitoring
SESAR3 ATM 总体规划和监控
批准号:
10091957
负责人:
金额:
$27.2万
依托单位:
依托单位国家:
英国
项目类别:
EU-Funded
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Master Planning and Monitoring project (so called AMPLE3 ) is to support the SESAR3 Joint Undertaking (S3JU) in planning and reporting on deployment activities in deployment (covering both industrialisation and implementation), and when need be, to contribute to the update the European ATM MP. The project provides Content Integration (CI) service to S3JU in support of the development activities and the delivery of a coherent set of SESAR Solutions aligned at content level with the S3JU MAWP direction and ambitions declined from the European ATM MP. While earlier SESAR Programmes addressed phases A, B and C of the SESAR Vision, the SESAR 3 JU Multi Annual Work Programme (MAWP) presents the strategic Research and Innovation (R&I) roadmaps of the Digital European Sky (DES) Programme to achieve also Phase D of the SESAR Vision. The MAWP identified several Transversal Activities (TA) to make the DES Programme not just a list of disconnected projects but a coherent programme, supporting delivery of SESAR Solutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
TSAb通过mTOR信号诱导线粒体缺陷性自噬在ATM中的作用及机制研究
  • 批准号:
    2026JJ81820
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张韵
  • 依托单位:
基于“去宛陈莝,精生形盛”探讨白芍七物颗粒通过CDK4/6-CCND1/2/3-ATM通路时序调控UC肠黏膜细胞周期与DNA损伤修复的机制研究
基于晶体结构和类药性质指导选择性ATM 小分子抑制剂的设计、合成及抗胶质母细胞瘤的活性机制研究
  • 批准号:
    JCZRQN202500438
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
新型铜载体天然产物Chalkphomycin通过ATM酶-CHK2-Cyclin D1轴抗黑色素瘤作用机制研究
  • 批准号:
    2025JJ80302
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    龚邦
  • 依托单位: